Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis

Increased myeloperoxidase (MPO) expression and activity are associated with atherosclerotic disease in patients with chronic kidney disease (CKD). However, the causal relationship between MPO and the development and progression of atherosclerosis in patients with CKD is unknown. Eight-week-old male...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Anna V., Zeng, Lixia, Atkins, Kevin B., Sadri, Kiana N., Byun, Jaeman, Fujiwara, Hideaki, Reddy, Pavan, Pennathur, Subramaniam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948401/
https://www.ncbi.nlm.nih.gov/pubmed/33234591
http://dx.doi.org/10.1074/jbc.RA120.014095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948401/
https://www.ncbi.nlm.nih.gov/pubmed/33234591
http://dx.doi.org/10.1074/jbc.RA120.014095

Ejemplares similares